Skip to content

Light Therapy in the Treatment of Leg Pain

Monochromatic Near-Infrared Light Energy (MIRE) in the Treatment of Tibial Stress Reaction

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00253981
Acronym
MilCAM
Enrollment
30
Registered
2005-11-15
Start date
2005-11-30
Completion date
2008-11-30
Last updated
2016-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Leg Injuries, Tibial Fractures

Keywords

Pain, Intractable, Infrared Rays, Leg

Brief summary

The purpose of this study is to apply Anodyne therapy to active duty soldiers, who have shin splints, to evaluate healing time and effectiveness.

Detailed description

Tibial stress reactions and fractures are often difficult to treat, and therefore, many soldiers proceed to a medical disability/discharge. It is felt that with the use of the MIRE technology, active duty soldiers with tibial stress reactions and fractures will heal more quickly and completely. All soldiers will have a documented bone scintigraph as evidence for tibial stress reaction or fracture prior to enrollment. In addition, pain-pressure goniometric measures and time to complete the Balke protocol will also be used to assess healing with the MIRE technology. Comparison: Soldiers with Active MIRE technology, compared to soldiers with Placebo MIRE technology.

Interventions

DEVICEMonochromatic Near-Infrared Light Energy (MIRE)

Subjects randomized to the intervention group (Monochromatic Near-Infrared Light Energy), received treatment three times a week for a total of four weeks.

Sponsors

William Beaumont Army Medical Center
CollaboratorFED
Samueli Institute for Information Biology
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
No

Inclusion criteria

* Active duty soldier * Exertional leg pain of greater than 3 months duration * Documented bone scintigraphic evidence for tibial stress reaction or fracture

Exclusion criteria

* Known leg Pathology other than stress reaction or fracture * Service members known to be leaving area within next 6 months * Pregnant females * High risk cardiopulmonary patients * Patients with assisted walking devices * Patients with two or more cardiac risk factors

Design outcomes

Primary

MeasureTime frameDescription
Visual Analog Scale4 weeksNumeric scale based on pain level (1-10). The higher the numeric value, the higher the pain level, as perceived by the participant.

Countries

United States

Participant flow

Recruitment details

The recruitment took place between 2006-2007 at a military treatment facility.

Pre-assignment details

Some participants were excluded due to deployment, military training that required them to leave the post.

Participants by arm

ArmCount
Experimental
The experimental group received the monochromatic light infrared energy treatment (MIRE).
16
Control
The control group followed the standard of care for the treatment of shin splints, usually physical therapy and medication.
14
Total30

Baseline characteristics

CharacteristicExperimentalControlTotal
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
0 Participants0 Participants0 Participants
Age, Categorical
Between 18 and 65 years
16 Participants14 Participants30 Participants
Region of Enrollment
United States
16 participants14 participants30 participants
Sex: Female, Male
Female
1 Participants0 Participants1 Participants
Sex: Female, Male
Male
15 Participants14 Participants29 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
— / —— / —
other
Total, other adverse events
0 / 160 / 14
serious
Total, serious adverse events
0 / 160 / 14

Outcome results

Primary

Visual Analog Scale

Numeric scale based on pain level (1-10). The higher the numeric value, the higher the pain level, as perceived by the participant.

Time frame: 4 weeks

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026